GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » YoY EBITDA Growth

MedMen Enterprises (MedMen Enterprises) YoY EBITDA Growth : -300.00% (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MedMen Enterprises's YoY EBITDA Growth for the quarter that ended in Mar. 2023 was -300.00%.

MedMen Enterprises's EBITDA per Share for the three months ended in Mar. 2023 was $-0.02.


MedMen Enterprises YoY EBITDA Growth Historical Data

The historical data trend for MedMen Enterprises's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises YoY EBITDA Growth Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.30 5.67 25.10 94.95 -19.23

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.47 -368.75 66.67 - -300.00

MedMen Enterprises YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MedMen Enterprises's YoY EBITDA Growth for the fiscal year that ended in Jun. 2022 is calculated as:

YoY EBITDA Growth (A: Jun. 2022 )
=(EBITDA per Share (A: Jun. 2022 )-EBITDA per Share (A: Jun. 2021 ))/ | EBITDA per Share (A: Jun. 2021 ) |
=(-0.093--0.078)/ | -0.078 |
=-19.23 %

MedMen Enterprises's YoY EBITDA Growth for the quarter that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (Q: Mar. 2023 )
=(EBITDA per Share (Q: Mar. 2023 )-EBITDA per Share (Q: Mar. 2022 )) / | EBITDA per Share (Q: Mar. 2022 )) |
=(-0.016--0.004)/ | -0.004 |
=-300.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.